Smith & Nephew PLC

SN.L · Health Technology · Medical Specialties · GB

17,914 employees · smith-nephew.com

About

Smith & Nephew PLC was founded in 1856 by Thomas James Smith in Hull, United Kingdom, as a manufacturer of bandages and orthopedic products. The company has since evolved into a globally operating healthcare company specializing in the manufacturing and distribution of medical devices. The company is divided into three business segments: Orthopaedics, Endoscopy, and Advanced Wound Management. The product range includes a wide range of products used for the treatment of injuries and diseases. This includes artificial joints, instruments for minimally invasive surgery, as well as wound care products such as dressings, compression stockings, and pain therapy systems. The Orthopaedics business segment offers a wide range of products for the treatment of arthritis, joint injuries, and other orthopedic conditions. This includes artificial joints, knee and hip prostheses, and implants for bone fracture stabilization. The company was one of the first to develop an artificial joint prosthesis and has since played a leading role in this field. The Endoscopy business segment provides instruments for minimally invasive surgery. These devices allow surgeons to perform less invasive surgical procedures that allow for faster patient recovery. The product range includes endoscopes, probes, and other instruments used for surgeries in the abdominal cavity, thoracic cavity, joints, and other areas of the body. Smith & Nephew's Advanced Wound Management business segment offers products for effective wound treatment. This includes wound dressings, compression stockings, shoes, and pain therapy systems. These products help reduce healing time and decrease the likelihood of infections. Smith & Nephew is headquartered in London, United Kingdom, and employs over 17,500 people worldwide. The company operates in more than 100 countries and has manufacturing facilities in Europe, Asia, and North America. In 2020, Smith & Nephew's revenue amounted to $4.6 billion. The business model of Smith & Nephew is based on innovation and the development of new technologies. The company invests a significant portion of its revenue each year in research and development to expand and improve its product range. Additionally, the company works closely with doctors and hospitals to better understand patient needs and offer tailored solutions. In recent years, Smith & Nephew has also invested in digital health. The company utilizes innovative technologies such as artificial intelligence and cloud solutions to provide better care and support to patients. This includes the introduction of mobile apps that assist patients in monitoring and self-treating their conditions. In conclusion, Smith & Nephew is a globally operating healthcare company specializing in the manufacturing and distribution of medical devices. The company has a wide product range used for the treatment of injuries and diseases. Its business model is based on innovation and the development of new technologies. Close collaboration with doctors and hospitals, as well as the utilization of digital technologies, are important pillars of the company.

Annual results

Reported figures, USD · revenue up 8.3% in 2025

YearRevenueNet incomeNet marginFree cash flow
20256.3B638M10.1%—
20245.8B412M7.1%—
20235.5B263M4.7%—
20225.2B223M4.3%—
20215.2B524M10.1%—

Dividends per share

2026 0.40 USD2025 0.29 USD2024 0.53 USD2023 0.30 USD2022 0.31 USD

SN.L in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Smith & Nephew PLC are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Smith & Nephew PLC (SN.L) — company profile and financials · MarketPulse